Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharada Katkuri

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Research|October 3, 2007
Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancerF Gregory Buchanan, Vijay Holla, Sharada Katkuri, et al.
Nature Medicine|February 6, 2004
Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growthRajnish A Gupta, Dingzhi Wang, Sharada Katkuri, et al.
The Journal of Biological Chemistry|November 3, 2004
Prostaglandin E2 regulates the complement inhibitor CD55/decay-accelerating factor in colorectal cancerVijaykumar R Holla, Dingzhi Wang, Joanne R Brown, et al.
Gastroenterology|August 9, 2005
Oncogenic potential of MEK1 in rat intestinal epithelial cells is mediated via cyclooxygenase-2Koga Komatsu, F Gregory Buchanan, Sharada Katkuri, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 7, 2006
Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progressionDingzhi Wang, Haibin Wang, Yong Guo, et al.
Cancer Cell|September 24, 2004
Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor deltaDingzhi Wang, Haibin Wang, Qiong Shi, et al.
The Journal of Biological Chemistry|November 16, 2004
15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancerMichael G Backlund, Jason R Mann, Vijaykumar R Holla, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Research|October 3, 2007
Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancerF Gregory Buchanan, Vijay Holla, Sharada Katkuri, et al.
Nature Medicine|February 6, 2004
Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growthRajnish A Gupta, Dingzhi Wang, Sharada Katkuri, et al.
The Journal of Biological Chemistry|November 3, 2004
Prostaglandin E2 regulates the complement inhibitor CD55/decay-accelerating factor in colorectal cancerVijaykumar R Holla, Dingzhi Wang, Joanne R Brown, et al.
Gastroenterology|August 9, 2005
Oncogenic potential of MEK1 in rat intestinal epithelial cells is mediated via cyclooxygenase-2Koga Komatsu, F Gregory Buchanan, Sharada Katkuri, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 7, 2006
Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progressionDingzhi Wang, Haibin Wang, Yong Guo, et al.
Cancer Cell|September 24, 2004
Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor deltaDingzhi Wang, Haibin Wang, Qiong Shi, et al.
The Journal of Biological Chemistry|November 16, 2004
15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancerMichael G Backlund, Jason R Mann, Vijaykumar R Holla, et al.
Pageof 1